CD39/CD73/A2aRs overexpression in the GME and their role in the immune suppression, tumor invasion, and angiogenesis suggest this pathway as an immunosuppressive candidate with high-priority in GME [55,111]. Here, ENTPD1 is linked to neoplasm.